Announced Wed, 8 Jul · 12:47 IST
Notice to shareholders on share transfer window and KYC campaign
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹41.49
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.3-1.2-1.4-2.4-1.2-2.7————
Up moveDown movePending
AI summary
Sandu Pharmaceuticals published newspaper notices about two SEBI initiatives: a one-year special window from Feb 5, 2026 to Feb 4, 2027 for re-lodging rejected physical share transfer requests filed before April 2019, and the 100-day Saksham Niveshak campaign ending July 9, 2026, asking shareholders to update KYC and nomination details to claim unpaid dividends before transfer to IEPF.
Likely market impact
Routine regulatory disclosure. Shareholders holding physical shares or unclaimed dividends should act before deadlines.